fibrolamellar hepatocellular carcinoma;CAR T cells;fusion proteins;Tumor;t cell receptor transgenic immunotherapy
-
Health News
Immunotherapy Targeting Cancer Fusion Protein May Hold Key to Treating Rare Liver Cancer
[ad_1] Newswise — (MEMPHIS, Tenn. – March 19, 2024) Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor…
Read More »